Followers | 373 |
Posts | 16790 |
Boards Moderated | 3 |
Alias Born | 03/07/2014 |
Thursday, October 30, 2014 10:39:42 AM
What does that even mean? There's no "IP" being "lent" to anyone? Where is that stated?
How much is a "ton" of revenue? A "ton" is a measure of weight??
Just from the 10-Q, Q-1 to 2014, to the 10-Q, Q-2, 2014, about a 3 month period, there was massive dilution, like a TON.
10-Q, period Q-1, 2014, PAGE 1:
As of May 6, 2014, there were 466,396,016 outstanding shares of the Registrant’s common stock, par value $0.001 per share.
Page 10, same 10-Q:
" Fully diluted shares outstanding were 498,696,292 and 222,688,816 for the three months ended March 31, 2014 and 2013, respectively."
10-Q, period Q-2, 2014, PAGE 1 (THREE SHORT MONTHS LATER)
As of August 1, 2014, there were 517,272,472 outstanding shares of the Registrant’s common stock, par value $0.001 per share.
Same 10-Q, Page 9:
"for the three months ended June 30, 2014 and for the three and six months ended June 30, 2014. Fully diluted shares outstanding were 588,670,163 and 290,900,920 for the three months ended June 30, 2014 and 2013,"
Thus in just the last 3 month reporting period, they diluted by (using fully diluted shares, which account for all derivative needs like options issued, warrants, etc):
588,670,163 - 498,696,292 = 89,973,871
Yep, 89 MILLION SHARES OF DILUTION from March 31, 2014 to June 30th, 2104. THAT IS MASSIVE DILUTION, on track for probably another 200 MILLION plus shares dilution for the year.
Notice also in the above 10-Q statements, showing the yr over yr periods, the SHARES O/S DOUBLED FROM 2013 to 2014 basically.
"Fully diluted shares outstanding were 588,670,163 and 290,900,920"
588 MILLION is pretty much a DOUBLE of 290 MILLION.
Again, site any 10-Q or 10-K filing page/pages that shows and proves otherwise please. Thanks
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM